FRANCESCHINI, Erica
 Distribuzione geografica
Continente #
NA - Nord America 13.281
AS - Asia 6.526
EU - Europa 6.378
SA - Sud America 979
Continente sconosciuto - Info sul continente non disponibili 238
AF - Africa 173
OC - Oceania 22
AN - Antartide 1
Totale 27.598
Nazione #
US - Stati Uniti d'America 12.828
IT - Italia 2.387
SG - Singapore 1.928
CN - Cina 1.529
GB - Regno Unito 1.262
VN - Vietnam 792
HK - Hong Kong 709
BR - Brasile 691
DE - Germania 616
BD - Bangladesh 515
SE - Svezia 440
RU - Federazione Russa 341
FI - Finlandia 296
FR - Francia 286
CA - Canada 276
KR - Corea 205
ID - Indonesia 161
IN - India 146
NL - Olanda 144
TR - Turchia 107
AR - Argentina 98
UA - Ucraina 80
MX - Messico 78
ES - Italia 73
BG - Bulgaria 71
JP - Giappone 71
PL - Polonia 56
LT - Lituania 53
IQ - Iraq 51
CO - Colombia 45
ZA - Sudafrica 45
PK - Pakistan 39
AE - Emirati Arabi Uniti 38
IE - Irlanda 35
CZ - Repubblica Ceca 32
AT - Austria 31
BE - Belgio 31
EC - Ecuador 31
SI - Slovenia 29
VE - Venezuela 29
CL - Cile 28
MA - Marocco 28
CR - Costa Rica 23
MY - Malesia 21
CH - Svizzera 20
IL - Israele 20
PE - Perù 20
AU - Australia 19
IR - Iran 18
PY - Paraguay 18
UZ - Uzbekistan 18
EG - Egitto 17
NP - Nepal 17
SA - Arabia Saudita 16
TH - Thailandia 16
PH - Filippine 15
JM - Giamaica 13
JO - Giordania 12
TN - Tunisia 12
TW - Taiwan 12
KE - Kenya 11
RO - Romania 11
AZ - Azerbaigian 10
DZ - Algeria 10
PR - Porto Rico 10
BO - Bolivia 9
ET - Etiopia 9
GR - Grecia 9
KZ - Kazakistan 9
OM - Oman 9
SN - Senegal 9
SV - El Salvador 9
GT - Guatemala 8
PA - Panama 8
PT - Portogallo 8
DK - Danimarca 7
GE - Georgia 7
HU - Ungheria 7
LV - Lettonia 7
NG - Nigeria 7
PS - Palestinian Territory 7
UY - Uruguay 7
AL - Albania 6
DO - Repubblica Dominicana 6
EE - Estonia 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
HN - Honduras 5
MK - Macedonia 5
BH - Bahrain 4
CI - Costa d'Avorio 4
MN - Mongolia 4
NO - Norvegia 4
RS - Serbia 4
SC - Seychelles 4
SD - Sudan 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
Totale 27.307
Città #
Ashburn 1.591
Santa Clara 1.210
Singapore 1.206
San Jose 927
Southend 768
Fairfield 734
Hong Kong 681
Chandler 575
Hefei 482
Council Bluffs 411
Houston 322
Seattle 317
Los Angeles 299
Woodbridge 282
New York 281
Nyköping 276
London 260
Beijing 245
Ho Chi Minh City 243
Cambridge 236
Wilmington 230
Dallas 229
Helsinki 219
Seoul 199
Milan 193
Modena 184
Hanoi 173
Munich 162
Chicago 160
Ann Arbor 151
Bologna 146
Rome 136
The Dalles 134
San Diego 124
Jakarta 122
Dearborn 98
Lauterbourg 98
Shanghai 91
Buffalo 89
Toronto 88
Moscow 80
Jacksonville 76
Atlanta 71
Princeton 65
São Paulo 63
Sofia 60
Orem 58
Tokyo 58
Naples 57
Frankfurt am Main 55
Parma 53
Boardman 52
Warsaw 49
Phoenix 47
Bremen 46
Salt Lake City 46
Turku 45
Montreal 43
Amsterdam 42
Columbus 42
Izmir 40
Redwood City 40
Fremont 39
Da Nang 38
Nuremberg 38
Reggio Emilia 38
North York 37
Haiphong 36
Mexico City 34
Brooklyn 33
Stockholm 32
Turin 32
Hillsboro 30
Johannesburg 28
San Francisco 28
Tampa 27
Brussels 26
Dublin 26
Falls Church 26
Kent 26
Palermo 26
Redondo Beach 26
Paris 25
Denver 24
Rimini 24
Catania 23
Chennai 23
Florence 22
Mumbai 22
Rio de Janeiro 22
Des Moines 21
Eugene 21
Verona 21
Elk Grove Village 20
Guangzhou 20
Madrid 20
Miami 20
Bari 19
Durham 19
Memphis 19
Totale 16.571
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 819
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 555
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 529
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 490
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 488
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 477
Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy 450
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 450
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 447
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 438
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 432
Metabolic reprograming shapes neutrophil functions in severe COVID-19 429
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 424
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 405
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 400
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 399
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 389
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 387
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 384
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 378
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 378
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 371
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 357
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 349
Hypokalemia in Patients with COVID-19 347
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 347
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 343
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 334
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 315
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 313
Peritoneal dialysis in the time of coronavirus disease 2019 312
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 301
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 298
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 294
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 291
Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient 288
Acid base disorders in patients with COVID-19 284
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 279
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 277
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 276
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 276
Engagement and retention in care of patients diagnosed with HIV infection and enrolled in the Modena HIV surveillance cohort. 274
Should we screen for NAFLD/NASH in HIV patients? 269
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial 268
Not just minor resections: robotic approach for cystic echinococcosis of the liver 268
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 265
Characteristics of HIV-infected patients not retained in care of two cohorts of northern Italy. 264
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 262
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 257
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 254
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 251
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 242
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 240
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 239
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 230
Central Nervous System Infections Caused by Bacillus Calmette-Guerin: Case Report and Narrative Literature Review 229
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 226
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 226
Death After Liver Transplantation: Mining Interpretable Risk Factors for Survival Prediction 225
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 225
Blackwater Fever Treated with Steroids in Nonimmune Patient, Italy 223
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 223
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 218
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 215
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: a prospective multicentre study 212
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort study 209
AKI in hospitalized patients with COVID-19: a single-center experience 200
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 199
Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients 197
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 196
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 190
The WEST Study: A Retrospective and Multicentric Study on the Impact of Steroid Therapy in West Nile Encephalitis 186
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 186
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 182
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 179
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 178
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 178
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 177
Role of Maraviroc in minimizing the risk of graft rejection in HIV-infected kidney transplant recipients 175
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia 174
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 170
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit 170
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 169
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection 166
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 159
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis 157
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 150
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study 150
Use of colistin in adult patients: A cross-sectional study 147
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 146
Monotherapy vs combination therapy for Enterococcus faecalis bacteremia: a target trial emulation 145
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 141
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 135
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge—Brief Report and Review of the Literature 133
Distinct leishmania infantum strains circulate in humans and dogs in the Emilia-Romagna region, northeastern Italy 131
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 121
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy 107
Streptococcus pneumoniae bacteremia: comparison of incidence, epidemiology, and clinical outcome in a pre- and post-COVID-19 period 104
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study 83
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis 81
Totale 27.176
Categoria #
all - tutte 109.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.449 0 0 0 79 87 100 205 103 185 146 323 221
2022/20231.969 235 259 176 185 216 244 66 162 187 38 93 108
2023/20241.720 60 93 133 167 295 195 116 178 64 65 130 224
2024/20254.862 144 97 111 323 812 743 415 291 586 235 496 609
2025/202610.325 714 438 783 1.086 1.385 592 1.226 516 981 1.078 882 644
2026/20273.113 530 1.553 651 379 0 0 0 0 0 0 0 0
Totale 27.598